Florensis extends assortment with Syngenta Poinsettia

Florensis has obtained the rights from Express Seed to sell and produce Syngenta genetics in Europe in 2023. The acquisition of Syngenta Poinsettia genetics by Express Seed in America has made this possible.

Wim Mieremet, Corporate Product Manager Cuttings, is very happy with this development. "Sales will start in 2023, among which the key varieties from these genetics like Titan, Mars, Mira, and Mirage. This makes our Poinsettia assortment even more attractive to our customers. The mother stock production will take place at one of our production locations in Ethiopia. Our partner P. van der Haak in The Netherlands becomes responsible for the young plants production."

Next year Florensis will present the best varieties from Decock Plants, Lazzeri, and Syngenta breeding, to offer a complete range to our customers.

For more information:
Langeweg 77-85
3342 LD Hendrik-Ido-Ambacht
T: +31 78 623 3200
F: +31 78 610 4411
E: florensis@florensis.com


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.